Gene · 7317
Papers2,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failure. | Clin Exp Med | 2025 | 40846800 | PubTator, text mining | PubMed |
| USP5-Rich Apoptotic Extracellular Vesicles Regulate Nucleus Pulposus Cells Apoptosis and DNA Damage Repair by Preventing E2F1 Proteasomal Degradation. | J Extracell Vesicles | 2025 | 40831373 | PubTator, text mining | PubMed |
| Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, and Somatic (VEXAS) Syndrome Presenting With Bicytopenia and Vasculitis. | Cureus | 2025 | 40821326 | PubTator, text mining | PubMed |
| Refractory myelodysplasia cutis in a patient with progression to acute myeloid leukaemia. | An Bras Dermatol | 2025 | 40812225 | PubTator, text mining | PubMed |
| VEXAS: A review of current understandings and emerging treatment strategies. | Front Immunol | 2025 | 40791602 | PubTator, text mining | PubMed |
| Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS syndrome management. | Curr Res Transl Med | 2025 | 40784090 | PubTator, text mining | PubMed |
| A cross-sectional survey on VEXAS syndrome: insights from a global expert panel. | Clin Rheumatol | 2025 | 40782278 | PubTator, text mining | PubMed |
| Is immunotherapy safe and effective in patients with VEXAS syndrome? | J Immunother Cancer | 2025 | 40744666 | PubTator, text mining | PubMed |
| Recent progress in clonal hematopoiesis: expanding the concept. | Int J Hematol | 2025 | 40742698 | PubTator, text mining | PubMed |
| Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome. | Blood | 2025 | 40729686 | PubTator, text mining | PubMed |
| Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature. | Open Access Rheumatol | 2025 | 40718755 | PubTator, text mining | PubMed |
| Developing efficient predictive models for the diagnosis of VEXAS syndrome. | Semin Arthritis Rheum | 2025 | 40712274 | PubTator, text mining | PubMed |
| Elaboration of molecular glues that target TRIM21 into TRIMTACs that degrade protein aggregates. | Nat Commun | 2025 | 40670348 | PubTator, text mining | PubMed |
| Fatal haemorrhage in VEXAS syndrome: a lethal complication unveiled. | BMJ Case Rep | 2025 | 40669885 | PubTator, text mining | PubMed |
| VEXAS syndrome-associated tumefactive demyelination. | J Neurol | 2025 | 40650768 | PubTator, text mining | PubMed |
| Vexas Syndrome in a Moroccan Patient: The Story of a Two-Year Diagnostic Lag. | Eur J Case Rep Intern Med | 2025 | 40636229 | PubTator, text mining | PubMed |
| Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome With Multisystem Involvement: Imaging and Genetic Insights From a Case Report. | Cureus | 2025 | 40600106 | PubTator, text mining | PubMed |
| Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome. | Leukemia | 2025 | 40588566 | PubTator, text mining | PubMed |
| Momelotinib Is Effective in Treatment for VEXAS Syndrome: Two Cases Within the AGMT Austrian Myeloid Registry. | Eur J Haematol | 2025 | 40582709 | PubTator, text mining | PubMed |
| VEXAS Syndrome and Alzheimer's Disease-Are There Connections? | Brain Sci | 2025 | 40563745 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7317/papers?page=9